Provided by Tiger Fintech (Singapore) Pte. Ltd.

Qiagen NV

42.07
-0.9900-2.30%
Post-market: 42.070.00000.00%19:58 EDT
Volume:896.40K
Turnover:37.80M
Market Cap:9.09B
PE:110.54
High:42.59
Open:42.50
Low:41.82
Close:43.06
Loading ...

QIAGEN Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025

Business Wire
·
23 Apr

Is There An Opportunity With Qiagen N.V.'s (NYSE:QGEN) 33% Undervaluation?

Simply Wall St.
·
23 Apr

Qiagen Is Maintained at Neutral by Baird

Dow Jones
·
21 Apr

Qiagen price target raised to $43 from $42 at Baird

TIPRANKS
·
21 Apr

Qiagen Plans 3 New Sample Preparation Instrument Launches Through 2026

MT Newswires Live
·
16 Apr

Market Chatter: Qiagen Holds Talks With Fivespan as Activist Investor Builds Stake

MT Newswires Live
·
16 Apr

Activist Fivespan built stake in Qiagen, holding talks, Bloomberg reports

TIPRANKS
·
16 Apr

QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation

Business Wire
·
15 Apr

Life Sciences Companies Likely to See Surprisingly Good 1Q Results -- Market Talk

Dow Jones
·
15 Apr

BofA Securities Cuts Price Target on Qiagen to $50 From $55, Maintains Buy Rating

MT Newswires Live
·
14 Apr

Press Release: QIAGEN N.V. to Release Results for Q1 2025 and Hold Webcast

Dow Jones
·
08 Apr

QIAGEN on Pace for Largest Percent Increase Since February 2024 -- Data Talk

Dow Jones
·
08 Apr

Qiagen Shares Rise Premarket As Preliminary Q1 Results, Hikes FY25 EPS Guidance

Benzinga
·
07 Apr

Qiagen Shares Rise After Guidance Lift

Dow Jones
·
07 Apr

Jefferies Remains a Buy on Qiagen (QGEN)

TIPRANKS
·
07 Apr

LIVE MARKETS-Sell everything!

Reuters
·
07 Apr

Qiagen Q1 Preliminary Adjusted Earnings Beat Guidance; 2025 Outlook Lifted

MT Newswires Live
·
07 Apr

Reported Sunday, QIAGEN Preliminary Q1 2025 Revenue ~$483M And Expects Adj. EPS Of At least $0.55 (Vs. $0.56 Est.); Raised 2025 EPS Target To ~$2.35 (Vs. $2.48 Est.) From Prior $2.28

Benzinga
·
07 Apr

Press Release: QIAGEN Delivers Strong Preliminary Q1 2025 Results Exceeding Outlook and Raises Full-Year 2025 Adjusted EPS Outlook

Dow Jones
·
07 Apr

Qiagen Says Q1 Adjusted EPS $0.55

Reuters
·
07 Apr